| Updated in 11/13/2018 11:52:07 AM |
Viewed: 341 times |
(Journal Article) |
Dianne H Dapito
,
Ali Mencin
,
Geum-Youn Gwak
,
Jean-Philippe Pradere
,
Myoung-Kuk Jang
,
Ingmar Mederacke
,
Jorge M Caviglia
,
Hossein Khiabanian
,
Adebowale Adeyemi
,
Ramon Bataller
,
Jay H Lefkowitch
,
Maureen Bower
,
Richard Friedman
,
R Balfour Sartor
,
Raul Rabadan
,
Robert F Schwabe
ABSTRACT
Increased translocation of intestinal bacteria is a hallmark of chronic liver disease and contributes to hepatic inflammation and fibrosis. Here we tested the hypothesis that the intestinal microbiota and Toll-like receptors (TLRs) promote hepatocellular carcinoma (HCC), a long-term consequence of chronic liver injury, inflammation, and fibrosis. Hepatocarcinogenesis in chronically injured livers depended on the intestinal microbiota and TLR4 activation in non-bone-marrow-derived resident liver cells. TLR4 and the intestinal microbiota were not required for HCC initiation but for HCC promotion, mediating increased proliferation, expression of the hepatomitogen epiregulin, and prevention of apoptosis. Gut sterilization restricted to late stages of hepatocarcinogenesis reduced HCC, suggesting that the intestinal microbiota and TLR4 represent therapeutic targets for HCC prevention in advanced liver disease.